Delta 9-Tetrahydrocannabinol (THC) is Effective in the Treatment of Tics in Tourette Syndrome: a 6-Week Randomized Trial
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Background Preliminary studies suggested that delta-9-tetrahydrocannabinol (THC), the major psychoactive ingredient of Cannabis sativa L., might be effective in the treatment of Tourette syndrome (TS). This study was performed to investigate for the first time under controlled conditions, over a longer-term treatment period, whether THC is effective and safe in reducing tics in TS. Method In this randomized, double-blind, placebo-controlled study, 24 patients with TS, according to DSM-III-R criteria, were treated over a 6-week period with up to 10 mg/day of THC. Tics were rated at 6 visits (visit 1, baseline; visits 2-4, during treatment period; visits 5-6, after withdrawal of medication) using the Tourette Syndrome Clinical Global Impressions scale (TS-CGI), the Shapiro Tourette-Syndrome Severity Scale (STSSS), the Yale Global Tic Severity Scale (YGTSS), the self-rated Tourette Syndrome Symptom List (TSSL), and a videotape-based rating scale. Results Seven patients dropped out of the study or had to be excluded, but only 1 due to side effects. Using the TS-CGI, STSSS, YGTSS, and video rating scale, we found a significant difference (p Conclusion Our results provide more evidence that THC is effective and safe in the treatment of tics. It, therefore, can be hypothesized that the central cannabinoid receptor system might play a role in TS pathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,064
Glass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
Giuffrida, A., Parsons, L. H., Kerr, T. M., de Fonseca, F. R., Navarro, M., & Piomelli, D. (1999) · Nature Neuroscience · doi:10.1038/7268 · Cited by 775
Tourette syndrome, associated conditions and the complexities of treatment
Robertson, M. M. (2000) · Brain · doi:10.1093/brain/123.3.425 · Cited by 704
CB1 Cannabinoid Receptor Inhibits Synaptic Release of Glutamate in Rat Dorsolateral Striatum
Gerdeman, G., & Lovinger, D. M. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.1.468 · Cited by 433
A Functional Neuroanatomy of Tics in Tourette Syndrome
Stern, E., Silbersweig, D. A., Chee, K.-Y., Holmes, A., Robertson, M. M., Trimble, M., Frith, C. D., Frackowiak, R. S. J., & Dolan, R. J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.741 · Cited by 333
di Marzo, V., Hill, M. P., Bisogno, T., Crossman, A. R., & Brotchie, J. M. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.10.1432 · Cited by 303
Auclair, N., Otani, S., Soubrie, P., & Crepel, F. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.83.6.3287 · Cited by 290
Treatment of Tourette's Syndrome with Δ9-Tetrahydrocannabinol (THC): A Randomized Crossover Trial
Müller-Vahl, K., Schneider, U., Koblenz, A., Jöbges, M., Kolbe, H., Daldrup, T., & Emrich, H. (2002) · Pharmacopsychiatry · doi:10.1055/s-2002-25028 · Cited by 256
Self-citationA New Instrument for Clinical Studies of Tourette's Syndrome
HARCHERIK, D. F., LECKMAN, J. F., DETLOR, J., & COHEN, D. J. (1984) · Journal of the American Academy of Child Psychiatry · doi:10.1097/00004583-198403000-00006 · Cited by 193
Maneuf, Y. P., Nash, J. E., Crossman, A. R., & Brotchie, J. M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00326-3 · Cited by 139
Cannabinoids: possible role in patho‐physiology and therapy of Gilles de la Tourette syndrome
Müller‐Vahl, K. R., Kolbe, H., Schneider, U., & Emrich, H. M. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10127.x · Cited by 108
Self-citationMarijuana and Tourette??s Syndrome
Sandyk, R., & Awerbuch, G. I. (1988) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198812000-00021 · Cited by 87
A rating scale for Gilles de la Tourette's syndrome: Description, reliability, and validity data
Goetz, C. G., Tanner, C. M., Wilson, R. S., & Shannon, K. M. (1987) · Neurology · doi:10.1212/wnl.37.9.1542 · Cited by 86
Pertwee, R. G., & Wickens, A. P. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90150-a · Cited by 84
Effective treatment of Tourette's syndrome with marijuana
Hemming, M., & Yellowlees, P. M. (1993) · Journal of Psychopharmacology · doi:10.1177/026988119300700411 · Cited by 83
Neurosurgery for Obsessive-Compulsive Disorder: Problems With Comorbidity
Albucher, R. C., Curtis, G. C., & Pitts, K. P. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.3.495a · Cited by 82
Pertwee, R. G., & Ross, T. M. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90044-c · Cited by 78
Interactions of Δ9-tetrahydrocannabinol with d-Amphetamine, cocaine, and nicotine in rats
Pryor, G. T., Larsen, F. F., Husain, S., & Braude, M. C. (1978) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(78)90320-9 · Cited by 74
Navarro, M. A., Fernández‐Ruíz, J., de Miguel, R., Hernández, M., Cebeira, M., & Ramos, J. A. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90241-k · Cited by 74
Current issues in Tourette syndrome
Singer, H. S. (2000) · Movement Disorders · doi:10.1002/1531-8257(200011)15:6<1051::aid-mds1001>3.0.co;2-l · Cited by 73
Müller-Vahl, K. R., Koblenz, A., Jöbges, M., Kolbe, H., Emrich, H. M., & Schneider, U. (2001) · Pharmacopsychiatry · doi:10.1055/s-2001-15191 · Cited by 66
Self-citationTetrahydrocannabinol potentiates reserpine-induced hypokinesia
Moss, D. E., McMaster, S. B., & Rogers, J. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90022-8 · Cited by 63
Richter, A., & Löscher, W. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00490-0 · Cited by 44
Neurochemistry and synaptic neurotransmission in Tourette syndrome.
Singer, H. S., & Wendlandt, J. T. (2001) · PubMed · Cited by 33
Cited by
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.6358 · Cited by 2,169
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957
The endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090
Russo, E., & Guy, G. W. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.026 · Cited by 610
Metadata
- Authors
- Muller-Vahl, K. R., Schneider, U., Prevedel, H., Theloe, K., Kolbe, H., Daldrup, T., & Emrich, H. M.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Heinrich Heine University Düsseldorf (DE)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2003-04-15
- Volume
- 64
- Issue
- 4
- Pages
- 459-465
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1981252279
- Cited by
- 270
- References
- 29
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 13 · 2023: 17 · 2022: 27 · 2021: 15 · 2020: 20 · 2019: 15 · 2018: 12 · 2017: 10 · 2016: 12 · 2015: 11 · 2014: 6 · 2013: 5 · 2012: 10
- FWCI
- 16.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- delta-9-tetrahydrocannabinol, Tourette syndrome, tics, cannabis, tic reduction, drug safety, Tourette syndrome treatment
- MeSH terms
- Adolescent, Adult, Double-Blind Method, Drug Administration Schedule, Female, Tourette Syndrome, Humans, Male, Middle Aged, Personality Inventory, Placebos, Psychiatric Status Rating Scales, Receptors, Drug, Severity of Illness Index, Dronabinol, Treatment Outcome, Tics, Receptors, Cannabinoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.